05.04.17
Alcami Corp., a provider of custom development and manufacturing services for the pharma and biopharma industries, is investing $5 million to expand its Charleston, SC operations. This project is expected create at least 30 new jobs.
Alcami will continue to expand its filling and freeze-drying capabilities. The site has also produced clinical supply from its recently-qualified second line and doubled both its filling capacity and freeze-drying capacity with increased scheduling flexibility, including a third operating shift. Hiring for the new positions is currently underway.
"The Charleston facility is an integral part of the Alcami network. We are excited about the growth potential of the site and its ability to support the increased demand for sterile drug product development and manufacturing," said Dr. Stephan Kutzer, Alcami’s chief executive officer, chairman and president.
Alcami offers services across active pharmaceutical ingredients, drug products (sterile, oral solid dose, packaging and labeling), development services and analytical testing, with six locations in the U.S., and a seventh in the Netherlands.
Alcami will continue to expand its filling and freeze-drying capabilities. The site has also produced clinical supply from its recently-qualified second line and doubled both its filling capacity and freeze-drying capacity with increased scheduling flexibility, including a third operating shift. Hiring for the new positions is currently underway.
"The Charleston facility is an integral part of the Alcami network. We are excited about the growth potential of the site and its ability to support the increased demand for sterile drug product development and manufacturing," said Dr. Stephan Kutzer, Alcami’s chief executive officer, chairman and president.
Alcami offers services across active pharmaceutical ingredients, drug products (sterile, oral solid dose, packaging and labeling), development services and analytical testing, with six locations in the U.S., and a seventh in the Netherlands.
